Unknown

Dataset Information

0

Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis.


ABSTRACT: Signaling receptors are internalized and regulated by clathrin-mediated endocytosis (CME). Two clathrin light chain isoforms, CLCa and CLCb, are integral components of the endocytic machinery whose differential functions remain unknown. We report that CLCb is specifically upregulated in non-small-cell lung cancer (NSCLC) cells and is associated with poor patient prognosis. Engineered single CLCb-expressing NSCLC cells, as well as "switched" cells that predominantly express CLCb, exhibit increased rates of CME and altered clathrin-coated pit dynamics. This "adaptive CME" resulted from upregulation of dynamin-1 (Dyn1) and its activation through a positive feedback loop involving enhanced epidermal growth factor (EGF)-dependent Akt/GSK3? phosphorylation. CLCb/Dyn1-dependent adaptive CME selectively altered EGF receptor trafficking, enhanced cell migration in vitro, and increased the metastatic efficiency of NSCLC cells in vivo. We define molecular mechanisms for adaptive CME in cancer cells and a role for the reciprocal crosstalk between signaling and CME in cancer progression.

SUBMITTER: Chen PH 

PROVIDER: S-EPMC5740869 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis.

Chen Ping-Hung PH   Bendris Nawal N   Hsiao Yi-Jing YJ   Reis Carlos R CR   Mettlen Marcel M   Chen Hsuan-Yu HY   Yu Sung-Liang SL   Schmid Sandra L SL  

Developmental cell 20170201 3


Signaling receptors are internalized and regulated by clathrin-mediated endocytosis (CME). Two clathrin light chain isoforms, CLCa and CLCb, are integral components of the endocytic machinery whose differential functions remain unknown. We report that CLCb is specifically upregulated in non-small-cell lung cancer (NSCLC) cells and is associated with poor patient prognosis. Engineered single CLCb-expressing NSCLC cells, as well as "switched" cells that predominantly express CLCb, exhibit increase  ...[more]

Similar Datasets

| S-EPMC5792084 | biostudies-literature
| S-EPMC4557666 | biostudies-literature
| S-EPMC3172267 | biostudies-literature
| S-EPMC5702056 | biostudies-literature
| S-EPMC3979662 | biostudies-literature
| S-EPMC3809577 | biostudies-literature
| S-EPMC2770739 | biostudies-literature
| S-EPMC6157066 | biostudies-literature
| S-EPMC3849811 | biostudies-literature